Xtant Medical Holdings Inc

NYSE American:XTNTUnited States

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.

Contact Information

Headquarters

664 Cruiser LaneBELGRADE, MT, United States 59714

Phone

406-388-0480

Fax

302-636-5454

Executives

Independent Chairman of the Board

Stavros Vizirgianakis

President, Chief Executive Officer, Director

Sean Browne

Interim Chief Financial Officer

Scott Neils

Chief Operating Officer

Mark Schallenberger

Chief Commercial Officer

Kevin Brandt